Adherence to Guideline Recommendations for Antiarrhythmic Drugs in Atrial Fibrillation

American Heart Journal - United States
doi 10.1016/j.ahj.2013.08.010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Class 1C Antiarrhythmic Drugs in Atrial Fibrillation and Coronary Artery Disease

Journal of Cardiovascular Electrophysiology
Cardiovascular MedicinePhysiologyCardiology
2020English

Antiarrhythmic Drug Therapy for Atrial Fibrillation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

New Antiarrhythmic Drug for the Treatment of Atrial Fibrillation. Study Data, Clinical Guidelines, Regulatory Agency Recommendations

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2011English

The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2015English

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation

JAMA - Journal of the American Medical Association
Medicine
2005English

Failure of Antiarrhythmic Drugs to Prevent Experimental Reperfusion Ventricular Fibrillation

Circulation
Cardiovascular MedicinePhysiologyCardiology
1981English

Managing Atrial Fibrillation: Catheter Ablation or Antiarrhythmic Therapy?

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2009English

Effects of E-4031 on Atrial Fibrillation Threhold: A Comparative Study With Class I Antiarrhythmic Drugs.

Japanese Journal of Electrocardiology
1994English

Antiarrhythmic Drug Therapy for Atrial Fibrillation in Patients With Left Ventricular Dysfunction

Japanese Journal of Electrocardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy